Milestone strengthens support for regulatory-ready nicotine and tobacco product evaluation during Labstat’s 50th anniversary year.
KITCHENER, Ontario – May 21, 2026 – Labstat Inc., a Certified Group company and the world’s largest independent nicotine, tobacco, and nicotine contract research organization (CRO), announced today that it has been formally recognized as a Good Laboratory Practice (GLP) compliant facility under the Organisation for Economic Co-operation and Development (OECD) Principles of GLP through the Standards Council of Canada (SCC).
The recognition follows a comprehensive SCC inspection and reflects Labstat’s commitment to scientific rigor, quality systems, data integrity, and regulatory excellence. The certificate was issued May 13, 2026, with initial recognition dated May 4, 2026.
“Achieving OECD GLP recognition reflects the tremendous effort and discipline of our scientific, operational, and quality teams,” said Scott LaNeve, President of Labstat International Inc. “As Labstat celebrates 50 years of service, this milestone strengthens our ability to generate scientifically sound, high-quality data within robust quality systems for our global customer base.”
OECD GLP recognition helps ensure the consistency, reliability, quality, and integrity of non-clinical laboratory studies used to support regulatory submissions worldwide.
Labstat supports traditional tobacco products and next-generation nicotine products, including ENDS, oral nicotine products, heated tobacco products, cigarettes, and cigars. Its analytical chemistry, microbiology, in vitro toxicology, and regulatory science services support product stewardship, scientific assessment, PMTAs, and other international regulatory programs.
“This recognition signals that Labstat is equipped to support the scientific rigor required for new product development and regulatory submissions,” said LaNeve. “We are proud to support complex toxicology, chemistry, and microbiology programs for clients worldwide.”
“Labstat’s GLP recognition reflects Certified Group’s strategic commitment to expanding our CRO services to other products and providing our customers with the solutions and data they require for new products and enhancement to existing products,” said David Morgan, Certified Group CEO. “This achievement highlights the technical capability our customers rely on to move forward with confidence.”
With OECD GLP recognition, Labstat helps clients support:
- Non-clinical studies under OECD GLP principles.
- Aerosol, smoke, and oral nicotine product exposure preparation.
- Cytotoxicity, genotoxicity, and mechanistic endpoint testing.
- Analytical chemistry and microbiology evaluations.
- Regulatory submissions to FDA, Health Canada, and other agencies.
